larderlab
Explainer· Supplements

What omega-3 actually does in the body

What omega-3 actually does in the body
Evidence reviewed·04 sources cited·Dr. Soraya Khan, RDN
Vol. 1Issue 042026-06-28larderlab.com
Educational use only. Larderlab content is educational. Pantry, macro, and supplement guidance is not a substitute for medical advice. Consult a registered dietitian or your physician before making material changes to your diet or supplementation.

Omega-3s (EPA and DHA) are structural fats that lower triglycerides, support the brain and eyes, and modulate inflammation. What they do, and the dose that does it.

  1. 01

    EPA and DHA are the forms that matter

    Omega-3 is a family, but two long-chain forms do the work: EPA and DHA, found in oily fish. The plant omega-3, ALA, must be converted to EPA and DHA in the body, and that conversion is inefficient, roughly 5-10% (NIH ODS). This is why 'I eat flax' does not substitute for fish or fish oil: you get ALA but little of the active EPA and DHA. Source the long-chain forms directly.

  2. 02

    DHA is structural in the brain and eyes

    DHA is a primary structural component of neuronal and retinal cell membranes, where it keeps membranes fluid and supports signaling. This structural role is why DHA is emphasized during pregnancy and infancy for brain and visual development (NIH ODS). In adults the structural turnover is slower, so the day-to-day brain benefit of supplementing a well-nourished adult is smaller than the developmental case implies.

  3. 03

    They lower triglycerides, the best-proven effect

    The most reliable clinical effect is on blood triglycerides. At pharmacologic doses (2-4 g/day EPA+DHA), omega-3s lower triglycerides by ~15-30%, a dose-dependent effect (Skulas-Ray et al. 2019, AHA advisory). This is strong enough that prescription omega-3 products are approved for severe hypertriglyceridemia. General-health doses (250-500 mg/day) do not produce this magnitude; the triglyceride effect is a high-dose phenomenon.

  4. 04

    They modulate inflammation

    EPA and DHA are converted into resolvins and protectins, signaling molecules that actively resolve inflammation, and they partly displace omega-6-derived pro-inflammatory mediators. This mechanism underlies the modest benefit seen in rheumatoid arthritis joint symptoms at higher doses. It does not make omega-3 a general anti-inflammatory cure; the clinical effect is condition-specific and dose-dependent.

  5. 05

    The cardiovascular evidence is genuinely mixed

    This is where honesty matters. High-dose prescription EPA (icosapent ethyl, 4 g/day) reduced cardiovascular events in high-risk statin-treated patients in REDUCE-IT (Bhatt et al. 2019). But broad supplementation trials in lower-risk people (VITAL, ASCEND) found little or no event reduction. The read: omega-3 is not a blanket heart-protective for everyone, but high-dose EPA has a real role in specific high-risk patients under a clinician.

  6. 06

    The dose, and how to source it cost-effectively

    For general health, 250-500 mg combined EPA+DHA per day is a common target, met by ~2 servings of oily fish weekly (salmon, sardines, mackerel) or a supplement. Therapeutic triglyceride lowering needs 2-4 g/day under medical guidance. When buying fish oil, price the active dose, not the softgel: our fish oil ranking compares products by $/mg of EPA+DHA, because a '1000 mg fish oil' capsule is often only ~300 mg EPA+DHA.

Questions

What people ask us next.

Q01
What does omega-3 do in the body?
EPA and DHA serve structural and signaling roles. DHA is a major structural fat in the brain and retina; both are precursors to molecules that resolve inflammation. The best-proven clinical effect is lowering blood triglycerides by ~15-30% at pharmacologic doses (Skulas-Ray 2019). Cardiovascular-event benefit is real for high-dose EPA in high-risk patients but mixed in the general population.
Q02
What is omega-3 good for?
Most reliably, lowering triglycerides at higher doses. It has a documented structural role in brain and eye development (hence the pregnancy emphasis), a modest anti-inflammatory effect in conditions like rheumatoid arthritis, and a cardiovascular-event benefit specifically with high-dose prescription EPA in high-risk patients (Bhatt 2019). It is not a proven broad disease preventive for low-risk people.
Q03
Is fish oil the same as omega-3?
Fish oil is a source of omega-3, not a synonym. Fish oil contains the long-chain omega-3s EPA and DHA, which are the active forms. Plant sources provide ALA, a shorter omega-3 that the body converts to EPA and DHA only at ~5-10% efficiency (NIH ODS). So fish oil delivers omega-3 directly, while flax or chia delivers a precursor.
Q04
How much omega-3 per day should I take?
For general health, 250-500 mg of combined EPA+DHA per day, achievable with about two servings of oily fish weekly or a supplement. Lowering triglycerides therapeutically takes 2-4 g/day under medical guidance. When buying, read the EPA+DHA number, not the total fish-oil weight; our fish oil ranking compares products by $/mg of EPA+DHA.
Q05
Can I get enough omega-3 from plants?
Partly, but unreliably for EPA and DHA. Flax, chia, and walnuts supply ALA, which converts to the active EPA and DHA at only ~5-10% (NIH ODS). Vegetarians and vegans who want guaranteed EPA and DHA should use an algae-based omega-3 supplement, which provides the long-chain forms directly without fish.
Q06
Is more omega-3 always better?
No. The triglyceride benefit is dose-dependent up to a few grams, but very high doses can prolong bleeding time and, in some trials, modestly raised atrial fibrillation risk. General-health intake (250-500 mg/day) carries no such concern. High therapeutic doses (2-4 g/day) belong under clinician oversight, not as open-ended self-dosing.
Sources

Every claim, cited.

04 refs
  1. [01]NIH Office of Dietary Supplements. Omega-3 Fatty Acids Fact Sheet for Health Professionals. EPA/DHA/ALA, conversion efficiency, intake recommendations.
  2. [02]Skulas-Ray AC, Wilson PWF, Harris WS, et al. 2019. Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association. Circulation 140(12):e673-e691. ~15-30% triglyceride reduction at 2-4 g/day.
  3. [03]Bhatt DL, Steg PG, Miller M, et al. 2019. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT). N Engl J Med 380(1):11-22. High-dose EPA reduced events in high-risk statin-treated patients.
  4. [04]Dyerberg J, Madsen P, Moller JM, et al. 2010. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids 83(3):137-141. Triglyceride form more bioavailable than ethyl ester.
The Larderlab Team · byline

The Larderlab Team builds evidence-led frameworks for eating, lifting, and stocking a kitchen. We cite every claim. We publish the spreadsheet when possible. We buy what we review at retail price. When new data lands, we revise with a dated note.

Related

Next in this hub.

Dispatch · lead magnet~ 1 email / week

Get the Larderlab Macro Planner.

A Google Sheet that calculates your protein target, splits it across 3-5 meals, and ranks 20 protein sources by $/gram. Free. Copy-and-modify your own version.

By subscribing, you agree to our Privacy Policy. Unsubscribe anytime.